חזרה לתוצאות החיפוש

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

ישראלמגייס משתתפיםPHASE3

מצבים רפואיים

Chronic Lymphocytic Leukemia · Leukemia, Lymphocytic · Leukemia, B-cell · Small Lymphocytic Lymphoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Hadassah Medical Center, Jerusalem, Israel

    Study coordinator · 050-8573679
    Contact: Principal Investigator (Neta Goldschmidt)

  • Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

  • Pacific Cancer Medical Center, Inc, Anaheim, California, United States

    Study coordinator · 714-999-1465
    Contact: Principal Investigator (Veena Charu)

  • TOI Clinical Research, Cerritos, California, United States

    Study coordinator · 562-693-4477
    Contact: Principal Investigator (MICHAEL DEL ROSARIO)

  • Stanford School of Medicine-Cancer Clinical Trials Office, Palo Alto, California, United States

    Study coordinator · 650-498-6000
    Contact: Principal Investigator (Bita Fakhri)

  • California Cancer Associates for Research and Excellence, San Marcos, California, United States

  • Florida Cancer Specialists, Fort Myers, Florida, United States

    Study coordinator · 727-216-1143
    Contact: Principal Investigator (Jennifer Cultrera)

  • Cancer Specialists of North Florida -St Augustine, Saint Augustine, Florida, United States

    Study coordinator · 904-538-4488
    Contact: Principal Investigator (Ayed Ayed)

  • Florida Cancer Specialists East, West Palm Beach, Florida, United States

    Study coordinator · 561-366-4100
    Contact: Principal Investigator (Shachar Peles)

  • Hematology Oncology Clinic, Baton Rouge, Louisiana, United States

  • Tulane Cancer Center Office of Clinical Research, New Orleans, Louisiana, United States

  • American Oncology Partners of Maryland, PA, Bethesda, Maryland, United States

    Study coordinator · 301-571-0019
    Contact: Principal Investigator (Victor Priego)

  • St. Vincent Frontier Cancer Center, Billings, Montana, United States

    Study coordinator · 406-238-6685
    Contact: Principal Investigator (Patrick Cobb)

  • Cancer Care Associates of York, York, Pennsylvania, United States

  • Prisma Health Cancer Institute, Greenville, South Carolina, United States

  • Sarah Cannon Research Institute SCRI, Nashville, Tennessee, United States

    Study coordinator · 423-622-6212
    Contact: Principal Investigator (Bertrand Anz III)

  • Kelsey Research Foundation, Houston, Texas, United States

  • Lumi Research, Kingwood, Texas, United States

    Study coordinator · (832) 553-3661 ext. 122
    Contact: Principal Investigator (David Nguyen)

  • Virginia Cancer Institute, Richmond, Virginia, United States

    Study coordinator · 804-287-3000
    Contact: Principal Investigator (Yuvraj Choudhary)

  • Medical Oncology Associates, PS, Spokane, Washington, United States

    Study coordinator · 509-462-2273
    Contact: Principal Investigator (Arvind Chaudhry)

  • MultiCare Health System Institute for Research and Innovation, Spokane, Washington, United States

  • Alexander Fleming, Ciudad Autónoma de Buenos Aire, Argentina

    Study coordinator · +54 9 11 4051-0781
    Contact: Principal Investigator (María Del Rosario Custidiano)

  • Hospital Privado De Comunidad, Mar del Plata, Argentina

  • Clínica de Nefrología, Urología y Enfermedades Cardiovasculares, Santa Fe, Argentina

    Study coordinator · +54 (342) 4055449
    Contact: Principal Investigator (Manuela Moreira Rodriguez)

  • One Clinical Research, Nedlands, Australia

  • Western Health, Sunshine Hospital, St Albans, Australia

  • The Perth Blood Institute, West Perth, Australia

    Contact: Principal Investigator (Ross Baker)

  • Hanusch Krankenhaus, Vienna, Austria

  • Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg, Leuven, Belgium

    Study coordinator · +3216346880
    Contact: Principal Investigator (Ann Janssens)

  • VITAZ, Sint-Niklaas, Belgium

    Study coordinator · +32 3 760 2985
    Contact: Principal Investigator (Vanessa Van Hende)

  • Fundação Pio XII - Hospital de Câncer de Barretos, Barretos, Brazil

    Contact: Principal Investigator (Nelson Siqueira de Castro)

  • Upeclin - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - UNESP, Botucatu, Brazil

    Study coordinator · +55 14 3880-1663
    Contact: Principal Investigator (Rafael Dezen Gaiolla)

  • Hemocentro Unicamp, Campinas, Brazil

    Study coordinator · 55 19 3521-8630
    Contact: Principal Investigator (Fernando Vieira Pericole de Souza)

  • Hospital Uopeccan - Centro de Pesquisa Clinica, Cascavel, Brazil

    Study coordinator · +55 (45) 9 9135 1056
    Contact: Principal Investigator (Gabriela Almeida Garcia)

  • Centro Integrado de Oncologia de Curitiba, Curitiba, Brazil

  • Hospital Erasto Gaertner - Liga Paranaense de Combate ao Câncer, Curitiba, Brazil

    Study coordinator · (41) 9998-46033
    Contact: Principal Investigator (João Samuel de Holanda Farias)

  • Instituto do Câncer - Hospital São Vicente de Paulo, Passo Fundo, Brazil

    Study coordinator · 555421034130
    Contact: Principal Investigator (Moema Nene Santos)

  • Centro Gaucho Integrado - Mae de Deus Center, Porto Alegre, Brazil

    Study coordinator · +55 51 33072943
    Contact: Principal Investigator (Marcelo Capra)

  • Hospital de Clínicas de Ribeirão Preto, Ribeirão Preto, Brazil

    Study coordinator · 16 98112-6986
    Contact: Principal Investigator (Diego Villa Clé)

  • CEPHO - Centro de Estudos e Pesquisas de Hematologia e Oncologia, Santo André, Brazil

    Study coordinator · +55.11.4993-5491
    Contact: Principal Investigator (Debora Rodrigues Bonito)

  • Centro Integrado de Pesquisa Clinica, São José do Rio Preto, Brazil

    Study coordinator · +55 (17)3201-5000
    Contact: Principal Investigator (Carlos Eduardo Miguel)

  • Hospital BP, São Paulo, Brazil

    Study coordinator · 551135056675
    Contact: Principal Investigator (Danielle Leão Cordeiro de Farias)

  • Hospital da Clinicas da Faculdade de Medicina da USP, São Paulo, Brazil

    Study coordinator · +55 11 4573-7631
    Contact: Principal Investigator (Raphael Costa Bandeira de Melo)

  • Hospital Santa Marcelina, São Paulo, Brazil

    Study coordinator · 55 11 22173766
    Contact: Principal Investigator (Patricia de Paulo Giacon)

  • Royal Victoria Hospital-Montreal, Montreal, Canada

  • Hopital de L'Enfant Jesus, Québec, Canada

    Study coordinator · 418-525-4444 ext. 0
    Contact: Principal Investigator (Robert Delage)

  • Cancer Care Manitoba, Winnipeg, Canada

  • Inmunocel, Santiago, Chile

  • CeCim Biocinetic, Santiago, Chile

  • Sociedad de Investigaciones Médicas Limitada, Temuco, Chile

    Study coordinator · +56974316500
    Contact: Principal Investigator (Eduardo Yañez)

  • Centro de Investigaciones Clínicas Viña del Mar (CIC), Viña del Mar, Chile

  • The Second Xiangya Hospital of Central South University, Changsha, China

  • Hunan Cancer Hospital, Changsha, China

  • Sun Yat-sen University Cancer Center, Guangzhou, China

    Study coordinator · +86 13798032244
    Contact: Principal Investigator (He Huang)

  • Southern Medical University Nanfang Hospital, Guangzhou, China

    Study coordinator · +8613802426709
    Contact: Principal Investigator (Xutao Guo)

  • Hainan General Hospital, Haikou, China

  • First Affiliated Hosp of College of Med, Zhejiang University, Hangzhou, China

    Study coordinator · 86 13505716779
    Contact: Principal Investigator (Jie Jin)

  • The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China

  • Anhui Provincial Hospital, Hefei, China

    Study coordinator · 8613856007984
    Contact: Principal Investigator (Xingbing Wang)

  • The Second Hospital of Anhui Medical University, Hefei, China

    Study coordinator · +86 13855147434
    Contact: Principal Investigator (Zhai Zhimin)

  • Jiangxi Provincial Cancer Hospital, Nanchang, China

  • Guangxi Medical University Affiliated Tumor Hospital, Nanning, China

    Study coordinator · +86 13507711671
    Contact: Principal Investigator (Hong Cen)

  • Fudan University Shanghai Cancer Center, Shanghai, China

    Study coordinator · 13651680209
    Contact: Principal Investigator (Junning Cao)

  • Blood Institute of the Chinese Academy of Medical science, Tianjin, China

  • Tianjin Medical University General Hospital, Tianjin, China

  • Affiliated Cancer Hospital of Xinjiang Medical University, Ürümqi, China

  • Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, China

  • Wu Han Tongji Hospital, Wuhan, China

  • The Fourth Affiliated Hospital Zhejiang University School of Medicine, Yiwu, China

  • Fakultni nemocnice Brno, Brno, Czechia

    Study coordinator · (+420) 532 233 642
    Contact: Principal Investigator (Anna Panovska)

  • Fakultni nemocnice Hradec Kralove, Hradec Králové, Czechia

    Study coordinator · +420 777 846 836
    Contact: Principal Investigator (Martin Simkovic)

  • Fakultni Nemocnice Ostrava, Ostrava, Czechia

    Study coordinator · (+420) 597 372 749
    Contact: Principal Investigator (Jana Mihalyova)

  • Fakultni Nemocnice Plzen, Pilsen, Czechia

    Study coordinator · (+420) 377 103 722
    Contact: Principal Investigator (Daniel Lysak)

  • Fakultni nemocnice Kralovske Vinohrady, Prague, Czechia

    Study coordinator · (+420) 267 163 530
    Contact: Principal Investigator (Jan Novak)

  • Vseobecna fakultni nemocnice v Praze, Prague, Czechia

    Study coordinator · (+420)224962527
    Contact: Principal Investigator (Marek Trneny)

  • CHD Vendee, La Roche-sur-Yon, France

    Study coordinator · +33251446173
    Contact: Principal Investigator (Jessie Bourcier)

  • Centre Hospitalier du Mans, Le Mans, France

    Study coordinator · +33 2.43.43.29.59
    Contact: Principal Investigator (Kamel Laribi)

  • Centre Hospitalier Universitaire (Limoges) (CHU DUPUYTREN 1), Limoges, France

    Study coordinator · +33(0)555 05 88 22
    Contact: Principal Investigator (Nataliya Dmutruk)

  • CHU de Nantes - Hotel Dieu, Nantes, France

    Contact: Principal Investigator (Anne Lok)

  • Centre Antoine Lacassagne, Nice, France

    Study coordinator · 33 (0)4 92 03 10 35
    Contact: Principal Investigator (Luca INCHIAPPA)

  • Hopital de la Pitie Salpetriere, Paris, France

    Study coordinator · +33 1 42 16 15 96
    Contact: Principal Investigator (Damien Roos-Weil)

  • Centre Hospitalier Lyon Sud, Pierre-Bénite, France

    Study coordinator · +33 4 78 86 43 07
    Contact: Principal Investigator (Emmanuelle Ferrant)

  • Hôpital de Pontchaillou, Rennes, France

    Study coordinator · +33 299 28 4291
    Contact: Principal Investigator (Sophie De Guibert)

  • Centre de Lutte Contre le Cancer - Centre Henri Becquerel Normandie Rouen, Rouen, France

    Study coordinator · + 33 2 32 08 22 23
    Contact: Principal Investigator (Stephane Lepretre)

  • CHRU De Tours, Tours, France

    Study coordinator · +33 2 47 47 37 12
    Contact: Principal Investigator (Caroline Dartigeas)

  • Gemeinschaftspraxis für Hämatologie und Onkologie (Gefos), Dortmund, Germany

  • Onkologische Gemeinschaftspraxis / BAG, Dresden, Germany

    Study coordinator · +4935144950701
    Contact: Principal Investigator (Lutz Jacobasch)

  • Universitaetsklinikum Carl Gustav Carus an der TU Dresden, Medizinische Klinik und Poliklinik 1, Dresden, Germany

  • Universitätsklinikum Ulm, Ulm, Germany

  • Debreceni Egyetem Orvos-es Egészsegtudomanyi Centrum, Debrecen, Hungary

    Study coordinator · 3652255196
    Contact: Principal Investigator (Arpad Illes)

  • Markusovszky Egyetemi Oktatokorhaz, Szombathely, Hungary

  • Azienda Ospedaliera Nazionale Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy

    Study coordinator · 39 0131 206440
    Contact: Principal Investigator (Gioacchino Catania)

  • Policlinico Sant'Orsola Malpighi, Bologna, Italy

  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy

    Study coordinator · +390543739100
    Contact: Principal Investigator (Gerardo Musuraca)

  • IRCCS Ospedale San Raffaele, Milan, Italy

    Study coordinator · 39.02.26434797
    Contact: Principal Investigator (Paolo Ghia)

  • Istituto Europeo di Oncologia, Milan, Italy

    Study coordinator · +39 02 57489403
    Contact: Principal Investigator (Enrico Derenzini)

  • Azienda Unita Sanitaria Locale di Reggio Emilia, Reggio Emilia, Italy

  • Kumamoto University Hospital, Kumamoto, Japan

  • Yamagata University Hospital, Yamagata, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Hisayuki Yokoyama)

  • Dunedin Hospital, Dunedin, New Zealand

  • Waikato Hospital, Hamilton, New Zealand

  • Momentum Clinical Research, Newtown, New Zealand

    Contact: Principal Investigator (Robert Weinkove)

  • Middlemore Clinical Trials, Papatoetoe, New Zealand

    Study coordinator · + 64 212 618 734
    Contact: Principal Investigator (James Liang)

  • KO-MED Centra Kliniczne, Biała Podlaska, Poland

  • Szpital Uniwersytecki nr 1 im. Antoniego Jurasza, Bydgoszcz, Poland

    Study coordinator · +48696476575
    Contact: Principal Investigator (Marta Sobas)

  • Uniwersyteckie Centrum Kliniczne, Gdansk, Poland

    Study coordinator · 48585844357
    Contact: Principal Investigator (Monika Szarejko)

  • Pratia Onkologia Katowice, Katowice, Poland

    Study coordinator · +48 600 388 282
    Contact: Principal Investigator (Sabastian Grosicki)

  • Pratia MCM Krakow, Krakow, Poland

    Study coordinator · +48451077231
    Contact: Principal Investigator (Wojciech Jurczak)

  • Klinika Hematoonkologii i Transplantacji Szpiku,Samodzielny Publiczny Szpital Kliniczny Nr 1, Lublin, Poland

  • AIDPORT Sp. z o.o., Skórzewo, Poland

    Contact: Principal Investigator (Michal Kwiatek)

  • Uniwersytecki Szpital Kliniczny Klinika, Wroclaw, Poland

    Study coordinator · +48 784 25 76
    Contact: Principal Investigator (Tomasz Wrobel)

  • Inje Univ Busan Paik Hospital, Busan, South Korea

    Study coordinator · +82-51-890-6407
    Contact: Principal Investigator (Won Lee)

  • The Catholic University of Korea-Seoul St. Mary's Hospital, Seocho-Gu, South Korea

    Study coordinator · 02-2228-6056
    Contact: Principal Investigator (Ki-Seong Eom)

  • Seoul National University Hospital, Seoul, South Korea

    Study coordinator · 82 2 2072 3079
    Contact: Principal Investigator (Ja Min Byun)

  • Samsung Medical Center, Seoul, South Korea

  • Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

    Study coordinator · +34 93 556 5647
    Contact: Principal Investigator (Miguel Arguello de Tomas)

  • Hospital Clinic de Barcelona, Barcelona, Spain

  • Hospital Universitari Vall d'Hebron, Barcelona, Spain

    Study coordinator · +34 932746000
    Contact: Principal Investigator (Francesc Bosch Albareda)

  • Hospital Duran i Reynals, L'Hospitalet de Llobregat, Spain

  • Hospital Universitario Infanta Leonor-INTERNAL MED, Madrid, Spain

    Study coordinator · +34619249275
    Contact: Principal Investigator (Jose Hernandez Rivas)

  • Hospital Universitario Ramón y Cajal, Madrid, Spain

    Study coordinator · +34 91 3368637
    Contact: Principal Investigator (Javier Lopez Jimenez)

  • Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Spain

    Study coordinator · +34 91 191 68 80
    Contact: Principal Investigator (Garcia Vela Jose Antonio)

  • Hospital Costa Del Sol, Marbella, Spain

    Study coordinator · +34 (951) 976-957
    Contact: Principal Investigator (Angeles Medina Perez)

  • Clinica Universitaria De Navarra, Pamplona, Spain

    Study coordinator · 913531920 ext. 7511
    Contact: Principal Investigator (Rocio Figueroa Mora)

  • Hospital De Navarra, Pamplona, Spain

    Study coordinator · +34848428428
    Contact: Principal Investigator (Jose Maria Arguiñano Perez)

  • Hospital Universitario Marqués de Valdecilla, Santander, Spain

    Study coordinator · 942 31 52 75
    Contact: Principal Investigator (Lucrecia Yañez San Segundo)

  • Hospital Universitario Virgen Macarena, Seville, Spain

    Study coordinator · +34619848594
    Contact: Principal Investigator (Alicia Rodriguez Fernandez)

  • Hospital Universitario Virgen Del Rocio, Seville, Spain

    Study coordinator · +34955013277
    Contact: Principal Investigator (Fatima de la Cruz Vicente)

  • Chang Bing Show Chwan Memorial Hospital, Changhua, Taiwan

    Study coordinator · +886-4-7813-888#70290
    Contact: Principal Investigator (Cheng-Shyong Chang)

  • Chang Gung Memorial Hospital - Chiayi, Chiayi County, Taiwan

    Study coordinator · +886-5-3621000 ext:2106
    Contact: Principal Investigator (Yu-Ying Wu)

  • National Cheng-Kung Uni. Hosp., Tainan, Taiwan

  • Koo Foundation Sun Yan-Sen Cancer Center, Taipei, Taiwan

    Study coordinator · +886-2-28970011
    Contact: Principal Investigator (Tran-Der Tan)

  • Gazi University Faculty of Medicine, Ankara, Turkey (Türkiye)

  • 9 Eylul University Hospital, Balçova, Turkey (Türkiye)

  • Ege Üniversitesi, Bornova, Turkey (Türkiye)

  • Istanbul University Istanbul Medicine Faculty, Faith, Turkey (Türkiye)

    Study coordinator · +90 533 575 90 96
    Contact: Principal Investigator (Mustafa Nuri Yenerel)

  • American Hospital, Istanbul, Turkey (Türkiye)

  • Acıbadem Maslak Hastanesi, Istanbul, Turkey (Türkiye)

  • Ankara University Medicine Hospital, Mamak, Turkey (Türkiye)

    Study coordinator · 90 505 502 50 50
    Contact: Principal Investigator (Muhit Özcan)

  • Bristol Haematology and Oncology Centre, Bristol, United Kingdom

    Study coordinator · 0117 3421121
    Contact: Principal Investigator (Sanne Lugthart)

  • HOPE Centre, Leicester, United Kingdom

  • St Bartholomew's Hospital, London, United Kingdom

  • Singleton Hospital, Swansea, United Kingdom

    Study coordinator · 01792 285301
    Contact: Principal Investigator (Unmesh Mohite)
מובילי המחקר

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Study Director

    Eli Lilly and Company

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)